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Abstract 
Background: Doppler echocardiographic studies in patients with β-Thalassemia Major (β-TM) had shown different patterns of left 
ventricle (LV) systolic and diastolic dysfunctions.
Aim: This cross-sectional study was designed to study the LV systolic and diastolic function in patients with β-TM using Pulsed 
  Doppler (PD) Echocardiogram and assess the QTc interval and QT dispersion (QTd) on 12 leads ECG.
Method: All patients were evaluated clinically as well as by echocardiography and 12 leads ECG. The study included patients with 
β-TM (n = 38, age 15.7 ± 8.9 years), compared with an age-matched healthy control group (n = 38, age 15.9 ± 8.9 years).
Results: In 38 patients with β-TM Compared with healthy control group, The QTc interval and the QTd dispersion on ECG were 
increased with no significant difference mode echo showed that β-TM patients have thicker LV septal wall index (0.659 ± 0.23 
vs. 0.446 ± 0.219 cm/M2, P  0.001), posterior wall index (0.659 ± 0.235 vs. 0.437 ± 0.214 cm/M2, P  0.01), and larger LVEDD index 
is (3.99 ± 0.48 vs. 2.170 ± 0.57 cm/M2. P  0.05). Pulsed Doppler showed high LV trans-mitral E wave velocity index (70.818 ± 10.139 
vs. 57.532 ± 10.139, P  0.05) and E/A ratio (1.54 vs.1.23, P  0.01). The duration of deceleration time index (DT) and isovolumic 
relaxation time index (IVRT) were significantly shorter in patients with β-TM (150.234 ± 20.0.23 vs. 167.123 ± 167.123 ± 19.143 msec/
M2, P  0.01) and (60.647 ± 6.77 vs. 75.474 ± 5.83 msec/M2, P  0.001), respectively. The tricuspid valve velocity in patients with 
β-TM was significantly higher than controls (2.993 ± 0.569 vs. 1.93 ± 0.471 m/sec, respectively, P  0.01), with calculated pulmonary 
artery pressure of 2.4 times the control (36.0 vs. 14.8 mmHg). However, the LVEF% or fractional shortening were not significantly 
different.
Conclusion: In this study, β-thalassemia major patients compared with controls have differences of QT dispersion and corrected QT 
interval that is of no statistical significance. A significantly thicker LV wall and LV diastolic filling indices are suggestive of restrictive 
diastolic pattern. These data indicate that LV diastolic abnormalities compromised initially in patients with β-thalassemia major.
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Introduction
Beta-Thalassemia Major (β-TM) is a genetic blood 
  disorder caused by reduced synthesis of β-globin chain. 
The consequences of chronic anemia include growth 
retardation, bone marrow expansion, extramedullary 
hematopoiesis, splenomegaly, greater intestinal iron 
absorption, hypercoagulability and higher suscepti-
bility to infection.1,2 Patients are usually maintained 
on  periodic  blood  transfusion  regimens  to  prevent 
complications and survive into adulthood. Because of 
the hemolysis and repeated blood transfusion, β-TM 
is associated with iron overload,3 The iron deposition 
could adversely affect both the structure and function 
of the heart. Previous studies indicated that patients 
with β-TM develop ventricular systolic dysfunction 
leading to congestive heart failure.4
The National Student Screening Project in Bahrain 
indicated that the prevalence of β-TM in high school 
students is 0.09%, with β-thalassaemia trait represent-
ing 2.9% of the sample population.5 Similar findings 
were observed in a study targeting subjects seeking 
premarital screening in Bahrain.6
Echocardiographic changes in patients with β-TM 
had not been previously studied in Bahrain. Evalua-
tion of systolic and diastolic function by echo pulsed 
Doppler can assist in staging the disease progression 
and may help to prevent further cardiac damage by 
applying  intense  chelating  regimens  and  combina-
tion therapy.7 The left Ventricle (LV) diastolic filling 
measured by pulsed wave Doppler echocardiography 
reflect the diastolic filling characteristics of the LV 
and depends on various factors including LV ventricle 
relaxation, compliance, systolic function and loading 
conditions.8 LV Diastolic filling pattern has been clas-
sified into normal, restrictive and abnormal relaxation 
pattern on the basis of early filling E wave and late 
filling A wave on LV trans-mitral diastolic filling.9,10
QT  dispersion  (QTd),  defined  as  maximum  QT 
interval minus minimum QT interval, was proposed as 
an index of ventricular recovery times to distinguish 
myocardium that is homogenous from myocardium 
that display non-homogenicity in the repolarization 
time  of  myocardium.11  The  normal  range  of  QTd 
value is 10–70 ms with mean 29 ± 26 ms in young 
age.12 QTd had been shown to increase in a variety of 
cardiac diseases including acute myocardial infarc-
tion  (MI),  post  MI,  hypertrophic  cardio-myopathy, 
left ventricle hypertrophy of hypertension, heart 
  failure, idiopathic dilated cardiomyopathy and Long 
QT syndrome indicating general repolarization abnor-
mality in this group of patients.13–16
The  prognostic  value  of  QTd  had  been  evalu-
ated in patients with end stage renal disease patients 
requiring hemodialysis, and in patients with diabetes 
mellitus.17,18
β-TM  patients  require  repeated  transfusion  of 
packed  cell  (PC),  lysis  of  transfused  packed  cell 
releases much iron which is not excretable. Iron depo-
sition in the body organs especially in the heart, the 
kidney and the brain are the main reasons for these 
organ failure causing death during second decade.19 It 
has been shown that ventricular wall thickening may 
be altered by pathological iron deposition.20 The iron 
deposition may affect the ventricular recovery times 
due to inhomogencity in the repolarization time with 
altered QT interval and QTd.
So far the impact of iron deposition on the QTd 
interval in patients with thalssemia major has not been 
evaluated and we are determined to know whether OT 
interval and QTd alteration in this group of patients. 
Thus, the aim of this study is assess the QTc interval 
and QTd using 12 leads Electrocardiogram (ECG) 
and pulsed Doppler echocardiogram in patients with 
β-TM in Bahrain.
subjects and Methods
This  study  included  38  patients  with  transfusion-
dependent β-TM and 38 patients with no thalassemia 
were used as a control group. The study was con-
ducted during the interval from January 2009 to June 
2009. A constitutional ethical approval was obtained 
for the study.
Selection was consecutive from patients who are 
on regular follow-up in Pediatric Hematology clinic 
at Salmaniya Medical Complex (SMC) in Bahrain.
Patients were included if they had a follow-up for 
more than 3 years at SMC, with a confirmed diagno-
sis of β-TM based on electrophoresis. Each patient 
had received blood transfusions every three weeks to 
maintain hemoglobin levels above 9 g/dl since infancy. 
All patients had also been receiving desferrioxamine 
as  a  chelating  therapy  (25–50  mg/kg  body  weight 
by subcutaneous infusion with an infusion pump for 
8–12 h) regularly for at least 1 year. In the control 
group, patients were all with no valve disease, normal 
LV function and negative blood tests for thalassemia. QTc interval and dispersion in patients with thalassemia major
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They were selected from the pool of healthy patients 
who are referred for evaluation of systolic murmur 
and turned to have normal echo.
The range of age was counted on the selection to 
match the study patients. The blood samples in the 
control group were withdrawn one week after the per-
formance of echo and twelve leads ECG.
Patients  were  excluded  if  they  have  end  stage 
renal  disease  with  creatinine  clearance  of  30% 
of  normal,  severe  liver  disease,  diabetes  mellitus, 
  hypoparathyroidism, advanced heart failure, hyper-
trophic  cardiomyopathy  or  if  the  patient  is  taking 
active cardiac medications.
Each patient in the study had a clinical and hema-
tological  data  file  including  duration  of  disease, 
  cardiovascular  assessment  for  pulse  rate,  jugular 
venous  pressure  wave,  apex  beat,  blood  pressure, 
heart  sounds  and  presence  or  absence  of  murmur, 
ankle  edema  and  body  weight.  Data  of  the  blood 
hemoglobin, serum ferritin and creatinine concentra-
tions were all extracted.
Twelve leads eCg
All patients in the β-TM and the control group had 
12 leads ECG, the QT interval corrected for Heart rate 
was performed using Bazett21 formula in which the 
K value modified by Shipley22 (is 0.397 for men and 
0.415 for women). The twelve leads ECG recorded 
on each patient at 25 mm/s. Three consecutive cycles 
were measured in each of the chest leads (V1–V6) and 
from the three values a mean of QT was calculated in 
chest leads V1–V6. The QT dispersion was defined as 
the difference between maximum and minimum QT. 
The methods of measurement were as reported previ-
ously by Pye et al.23
Doppler echocardiography
All patients in the study group and the control group 
had the echo examination by 2.5–5 MHz transducer, 
using HP E33 echo machine. The echocardiographic 
measurements were done by the an echo technician 
who is not aware of the clinical status of the patients 
the  data  were  reviewed  by  a  second  technician 
blinded of the first results and an average of the two 
reading was tabulated for the 2-D and Doppler results 
the Doppler velocities and other echo findings were 
taken as an average of at least three cardiac cycles, 
according  to  the  criteria  of  the American  Society 
of Echocardiography.24 Each patient enrolled in the 
study had echocardiographic measurements including 
M Mode, 2D echo, color flow, systolic and diastolic 
myocardial indexes.
The  echo  parameters  including  the  left  ventricle 
(LV) septal wall thickness, posterior LV wall thickness, 
LV cavity dimension in systole, and LV dimension in 
diastole were all measured using the M mode tracing. 
LV fractional shortening (FS) and LV ejection fraction 
percentage (LVEF%) were measured using Teichholz 
formula: V = {7.0/(2.4 + D)*D3}. The presence of valve 
diseases and both the left and right atrial areas were all 
assessed in the apical four chamber view.
The left ventricle diastolic filling indices included 
early diastolic wave (E wave), late diastolic wave 
(A  wave),  deceleration  time  of  E  wave  (DT), 
  isovolumic relaxation time (IVRT) and E wave to 
A wave (E/A) ratio. The tricuspid valve velocity in 
systole as an index of pulmonary artery pressure was 
calculated  using  tricuspid  velocity  jet  in  modified 
Bernoulli equation {∆ p RV-RA = 4(VTR)2}.25
statistical analysis
All data were entered and analyzed using the Statisti-
cal Package of Social Sciences (SPSS) version 17.0. 
Data are presented as mean ±SD. Unpaired student 
t-test was used to analyze the differences between the 
variables in the control group and patients with β-TM. 
The QTd and echo Doppler findings were adjusted 
for Body Surface Area (BSA) in both groups. Differ-
ences between groups were considered statistically 
significant at a probability value of  0.05.
Results
The  demographic  data  on  the  β-TM  patients  and 
the healthy controls are summarized in Table 1. The 
  β-TM group had significantly lower body weight and 
height (P  0.001) and body surface area of 1.15 ± 0.2 
vs. 1.01 ± 0.2, P  0.05) compared with the control 
group.
The mean age was 15.7 ± 8.9 year (range: 7–25) 
and 57% male, while the mean age of the control group 
was 15.9 ± 8.3 year (range; 6–24) There was no sig-
nificant difference in the gender distribution between 
the two groups. The systolic and diastolic pressures 
values were comparable in both groups, but the heart 
rate was significantly higher by 27% in β-TM group. 
The serum ferritin level was significantly higher in garadah et al
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the  β-TM  group  compared  with  the  control  group 
(P  0.001). No significant differences in serum cre-
atinine and hemoglobin level between both groups.
Figure 1 showed the value of QTc and QTd in both 
groups. There was no significant difference in QTc 
between both groups. The QTc in the β-TM group was 
409 ± 23.034 ms vs. 402 ± 24.023 ms in the control 
group (P = 0.087). The QT d was slightly longer in the 
β-TM group compared with the control with no statis-
tical significance (41 ± 22.014 ms vs. 37 ± 20.164 ms, 
respectively, P = 0.078).
Echo doppler findings
Table 2 summarizes the echo Doppler findings in both 
control and β-TM groups. The β-TM group showed 
significantly  higher  LV  wall  thickness  manifested 
by  significantly  thicker  posterior  wall  and  inter-
  ventricular septum (P  0.001 in both). LV dimensions 
at the end of systole (ESD) and diastole (EDD) were 
significantly higher in β-TM compared with control 
group (P = 0.035 and P  0.001, respectively). How-
ever, no significant difference in left ventricle frac-
tional shortening (FS) and ejection fraction (LVEF%) 
between the two groups were observed. These data 
indicate compensated normal systolic function in the 
β-TM group.
Compared with controls, the β-TM group showed 
a significantly higher E wave (P = 0.027), higher E/A 
ratio (P = 0.021), shorter deceleration time of E wave 
(P  0.01) and shorter isovolumic relaxation time 
(IVRT) (P  0.01). These data indicate diastolic dys-
function of restrictive pattern in β-TM group.
The ratio of E wave velocity of the mitral to 
the  tissue  Doppler  of  the  septal  mitral  annulus 
(E/e- ratio) was significantly higher in the β-TM 
group compared to the control group (P  0.01), and 
the tricuspid valve velocity of right ventricle was 
significantly higher (P  0.01). In the β-TM group 
compared  with  the  control,  using  Bernoulli  equa-
tion for the tricuspid valve velocity, the calculated 
pulmonary artery pressure was 2.4 times the control 
(36.0 vs. 14.8 mmHg, respectively); the data is not 
shown in the table.
Finally,  the  left  and  right  atrial  areas  were  sig-
nificantly  larger  in  β-TM  group  compared  to  the 
control (P  0.01). The color flow and continuous 
flow of the LV in the β-TM group showed mild mitral 
Table 1. Demographic characteristics of control (n = 38) and thalassemia patients (n = 38) in the study population. Data are 
presented as mean ± sD. P value  0.05 is considered statistically significant.
parameter control Thalassemia P-value
Age (Years)
Male
15.79 ± 8.94
22 (57%)
15.92 ± 8.92
23 (60%)
0.92
0.75
Weight (kg) 33.00 ± 7.25 25.6 ± 8.30 0.034*
height (cm)
BsA
144.3 ± 9.62
1.15 ± 0.2
133.4 ± 9.64
1.02 ± 0.2
0.001*
0.001*
systolic pressure (mmhg) 123.34 ± 12.15 128.16 ± 12.03 0.108
Diastolic pressure (mmhg) 69.61 ± 7.06 70.71 ± 8.23 0.101
heart rate (BPM) 
serum ferritin (ug/l)
serum creatinine (umol/l)
hemoglobin gm/dl
67.58 ± 7.26
230 ± 22
80.8 ± 10.12
10.2 ± 0.5
92 ± 6.99
1628.6 ± 243.8
75.23 ± 11.13
9.5 ± 0.4
0.001*
0.001*
0.076
0.065
* = (P  0.05).
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Figure 1. The mean QT interval (QTc) and QT dispersion (QTd) in mil-
liseconds  in  patients  with  beta  thalassemia  major  (β-TM)  and  control 
healthy group.QTc interval and dispersion in patients with thalassemia major
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regurgitation in nine patients and three mild aortic 
regurgitation.
Discussion
In this study, patients with β-TM were evaluated with 
pulse Doppler echocardiogram for diastolic filling of 
left ventricle (LV) and 12 leads ECG for evaluation 
of QT interval and QT dispersion compared with age-
matched controls. The main findings are compared 
with controls, the diastolic indices of LV in β-TM 
patients showed higher early diastolic filling of LV 
and  high  E/A  ratio  suggesting  restrictive  diastolic 
pattern and thus stiff LV wall. These findings are in 
keeping with another study by Yaprak et al3,26 who 
demonstrated that β-TM patients (n = 63) had signifi-
cantly higher E wave, E/A ratio, and lower A wave 
velocity,  suggesting  restrictive  pattern  in  54%  in 
the study population; no correlation was found with 
hemoglobin level. Similarly, it has been reported that 
transmitral diastolic filling measured by Doppler in 
patients with β-TM (n = 32, none of them had heart 
failure) exhibits a restrictive pattern (Spirit P et al27). 
This was also in agreement with a previous report that 
high E/A ratio is the most common finding in patients 
with β-TM.28
The LVEF% and fractional shortening were normal 
with no difference between patients with β-TM and 
the control group. The normal LVEF% indicates that 
β-TM patients are having minimal deleterious effect 
of myocardial iron overload on myocardial systolic 
function and that was evident by the optimal level of 
serum ferritin in the study population. This may also 
explain the absence of heart failure and absence of 
significant valve diseases in the current study popula-
tion. In one report it was shown that the overall car-
diovascular prognosis was good if the serum ferritin 
is below 2500 ng/dl; the low ferritin of 1000 ng/dl 
was associated with normal LVEF% while high level 
was associated with low LVEF%.29 In another study, 
however,  right  sided  heart  failure  was  reported  in 
16%  of  β-TM  patients  with  high  serum  ferritin 
of 2500 ng/ml.30 Therefore, the iron overload in the 
current study appears to mediate the impaired dia-
stolic function with the development of pulmonary 
hypertension leading to stiffness of the myocardial 
wall. So it seems in this population and in keeping 
with  others  myocardial  disease  passes  through  a 
stage of impaired relaxation before development of 
systolic  dysfunction.31  With  mean  pre-transfusion 
hemoglobin concentration of 9.5 gm/dl in the β-TM 
group, there is an increase dimension of LV cavity 
and LV volume in systole and diastole as well as LV 
wall thickness. The increase of the volume load in 
this population may be a reflection of Frank Starling 
mechanism and may be due the increase of heart rate, 
this was observed by others who related the incre-
ment of LV volume to factors mediated by chronic 
anemia.32,33
The ECG heart rate corrected QT interval and the 
QT dispersion were slightly higher in the TM group 
Table 2. Echocardiographic findings in control (n = 38) and thalassemia patients (n = 38) in the study population. Data are 
presented as mean ± seM per body surface area (m2). P value  0.05 is considered statistically significant.
parameter control Thalassemia P-value
IVs/BsA (cm/M2) 0.446 ± 0.219 0.659 ± 0.26 0.001*
PW/BsA (cm/M2) 0.437 ± 0.214 0.659 ± 0.235 0.001*
LVeDD/BsA (mm/M2) 2.170 ± 0.57 3.995 ± 0.48 0.035*
LVesD/BsA (mm/M2) 2.217 ± 0.45 2.40 ± 0.54 0.001*
Fs (%) 31.329 ± 3.810 33.878 ± 4.944 0.107
LVeF (%) 57.656 ± 6.641 58.454 ± 6.504 0.103
e wave/BsA (cm/sec) 57.532 ± 12.959 70.818 ± 10.139 0.027*
A wave/BsA (cm/sec) 46.330 ± 9.851 44.646 ± 7.776 0.109
e/A ratio 1.233 ± 0.27 1.54 ± 0.235 0.021
DT/BsA (msec) 167.123 ± 19.143 150.234 ± 20.023 0.01
IVrT/BsA (msec) 75.474 ± 5.83 60.647 ± 6.770 0.01
Tricuspid velocity/BsA (m/sec) 1.453 ± 0.471 2.993 ± 0.569 0.01
Abbreviations: IVs, interventricular septal thickness; Pw, posterior wall thickness; LVeDD, left ventricle end diastolic diameter; LVesD, left ventricle end 
systolic diameter; Fs, fractional shortening; eF, left ventricle ejection fraction; e wave, mitral e wave peak velocity; A wave, mitral A wave peak velocity; 
DT, e wave deceleration time; IVrT, isovolumic relaxation time; Tr, tricuspid velocity.garadah et al
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compared with the control group with no statistical 
difference.
This ECG finding may indicate the mild impact of 
iron deposition in the myocardium in this group of 
patients and perhaps a long-term follow up for serum 
ferritin and QT dispersion may be warranted to evalu-
ate the temporal relationship between these two fac-
tors. The QTd was significantly increased in patients 
with coronary artery disease, end stage renal disease 
and in diabetes mellitus.16–18
Findings from the current study is in keeping with 
previous reports indicating that patients with β-TM 
have non significant increased of QTd compared with 
controls.34
However in this study, the increment of LV wall 
thickness and LV cavity dimensions, both can pos-
sibly lead to increase of the heterogenicity of repo-
larization  and  prolongation  of  QT  dispersion.  The 
significant increment of QTd in β-TM patients may 
be due to early disease involvement or the effective 
chelating therapy and transfusion regimen or both.
The  prolongation  of  QT  interval  is  associated 
with an increased risk of a characteristic life threat-
ening  cardiac  arrhythmia  and  hence  in  this  study 
the increment of QT interval may herald such late 
outcome.15
The magnitude of E wave velocity is governed 
by the initial left ventricle pressure and shown to be 
directly related to it.34 In this study, the decreased DT 
time of E wave was mostly related to the amplitude 
of the E wave and is due to the impaired relaxation 
of LV. The IVRT was also shortened reflecting the 
impaired LV relaxation pattern, probably due to iron 
overload stiffness of LV wall. In a previous report, 
it was shown that this period of time is influenced 
by many factors such as heart rate, BSA and age; so 
these factors need to be considered and adjusted.35
There  were  significantly  higher  velocity  across 
the  tricuspid  valve  in  the  β-TM  group  indicates 
early development of pulmonary hypertension in the 
β-TM group. This finding indicates the presence of 
early right ventricular dysfunction even before the 
development  of  LV  dysfunction  that  was  normal 
in this study. Pulmonary hypertension in the β-TM 
patients may be due to pulmonary diffusion defect, 
hypoxia and possibly airway obstruction due to iron 
overload.36–38
conclusion
We  conclude  from  this  study  that  β-thalassemia 
patients who are receiving periodic transfusions and 
chelation therapy have normal systolic function, larger 
left  ventricle  dimensions,  abnormal  LV  relaxation 
pattern suggestive of restrictive pattern, higher LV 
end-diastolic pressure. The QTc interval and the QT 
dispersion were not significantly increased in β-TM 
patients. These data suggests that diastolic abnormal-
ities appears initially in patients with β-thalassemia.
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